135 related articles for article (PubMed ID: 24702902)
1. Decreased serum nesfatin-1 levels in endometriosis.
Şengül Ö; Dilbaz B; Halıcı Z; Ferah I; Çadırcı E; Yılmaz F
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():34-7. PubMed ID: 24702902
[TBL] [Abstract][Full Text] [Related]
2. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.
Abaci A; Catli G; Anik A; Kume T; Bober E
Pediatr Diabetes; 2013 May; 14(3):189-95. PubMed ID: 23346951
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of serum levels of nesfatin-1 in children and adolescents with autoimmune thyroid diseases].
Sawicka B; Bossowski A
Pediatr Endocrinol Diabetes Metab; 2013; 19(1):5-10. PubMed ID: 23739643
[TBL] [Abstract][Full Text] [Related]
4. Is There a Relationship between Obstructive Sleep Apnea Syndrome Severity and Nesfatin-1?
Araz O; Yilmazel Ucar E; Dorman E; Bayraktutan Z; Yayla M; Yilmaz N; Acemoglu H; Halici Z; Akgun M
Respiration; 2015; 90(2):105-10. PubMed ID: 26088934
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Brain Neuropeptide (Nesfatin-1 and Orexin-A) Concentrations with Anthropometric and Biochemical Parameters in Malnourished Children.
Ustabaş Kahraman F; Vehapoğlu A; Özgen İT; Terzioğlu Ş; Cesur Y; Dündaröz R
J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):197-202. PubMed ID: 26831553
[TBL] [Abstract][Full Text] [Related]
6. Ghrelins, obestatin, nesfatin-1 and leptin levels in pregnant women with and without hyperemesis gravidarum.
Gungor S; Gurates B; Aydin S; Sahin I; Kavak SB; Kumru S; Celik H; Aksoy A; Yilmaz M; Catak Z; Citil C; Baykus Y; Deniz R; Karakaya F; Özdemir N
Clin Biochem; 2013 Jun; 46(9):828-30. PubMed ID: 23380589
[TBL] [Abstract][Full Text] [Related]
7. Decreased levels of serum nesfatin-1 in patients with preeclampsia.
Zhang C; Wang Y; Wang Y; Li J; Liu R; Liu H
Biomarkers; 2014 Aug; 19(5):402-6. PubMed ID: 24857385
[TBL] [Abstract][Full Text] [Related]
8. Serum nesfatin-1 levels in overt and subclinical hyperthyroidism.
Gungunes A; Ozbek M; Ginis Z; Sahin M; Demirci T; Cakir Ozkaya E; Karbek B; Sayki Arslan M; Ozturk Unsal I; Tutal Akkaya E; Ucan B; Gultuna Ozguclu S; Cakal E; Topaloglu O; Delibasi T
Minerva Endocrinol; 2014 Sep; 39(3):209-14. PubMed ID: 25068306
[TBL] [Abstract][Full Text] [Related]
9. The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation?
Saldanha JF; Carrero JJ; Lobo JC; Stockler-Pinto MB; Leal VO; Calixto A; Geloneze B; Mafra D
Regul Pept; 2012 Jan; 173(1-3):82-5. PubMed ID: 22036920
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus.
Zhang Z; Li L; Yang M; Liu H; Boden G; Yang G
Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):91-5. PubMed ID: 22020667
[TBL] [Abstract][Full Text] [Related]
11. Nesfatin-1 in advanced lung cancer patients with weight loss.
Cetinkaya H; Karagöz B; Bilgi O; Ozgün A; Tunçel T; Emirzeoğlu L; Top C; Kandemir EG
Regul Pept; 2013 Feb; 181():1-3. PubMed ID: 23269222
[TBL] [Abstract][Full Text] [Related]
12. Plasma nesfatin-1 level in obese patients after acupuncture: a randomised controlled trial.
Guo Y; Xing M; Sun W; Yuan X; Dai H; Ding H
Acupunct Med; 2014 Aug; 32(4):313-7. PubMed ID: 24813558
[TBL] [Abstract][Full Text] [Related]
13. NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.
Hofmann T; Stengel A; Ahnis A; Buße P; Elbelt U; Klapp BF
Psychoneuroendocrinology; 2013 Nov; 38(11):2502-10. PubMed ID: 23796625
[TBL] [Abstract][Full Text] [Related]
14. Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder.
Gunay H; Tutuncu R; Aydin S; Dag E; Abasli D
Psychoneuroendocrinology; 2012 Dec; 37(12):1949-53. PubMed ID: 22595767
[TBL] [Abstract][Full Text] [Related]
15. Nesfatin-1 hormone levels in morbidly obese patients after laparoscopic sleeve gastrectomy.
Dogan U; Bulbuller N; Cakır T; Habibi M; Mayir B; Koc U; Aslaner A; Ellidag HY; Gomceli I
Eur Rev Med Pharmacol Sci; 2016; 20(6):1023-31. PubMed ID: 27049252
[TBL] [Abstract][Full Text] [Related]
16. A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease.
Başar O; Akbal E; Köklü S; Koçak E; Tuna Y; Ekiz F; Gültuna S; Yιlmaz FM; Aydoğan T
Scand J Clin Lab Invest; 2012 Oct; 72(6):479-83. PubMed ID: 22950627
[TBL] [Abstract][Full Text] [Related]
17. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance.
Anwar GM; Yamamah G; Ibrahim A; El-Lebedy D; Farid TM; Mahmoud R
Regul Pept; 2014 Jan; 188():21-4. PubMed ID: 24333832
[TBL] [Abstract][Full Text] [Related]
18. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment.
Tan BK; Hallschmid M; Kern W; Lehnert H; Randeva HS
J Clin Endocrinol Metab; 2011 Apr; 96(4):E669-73. PubMed ID: 21252251
[TBL] [Abstract][Full Text] [Related]
19. Association of nesfatin-1 and fat mass in cystic fibrosis.
Cohen RI; Ginsberg N; Tsang D; Wann LC; Ye X; Liu SF
Respiration; 2013; 86(4):312-7. PubMed ID: 23306670
[TBL] [Abstract][Full Text] [Related]
20. The effect of nesfatin-1 levels on paroxysmal supraventricular tachycardia.
Celik A; Gurger M; Can Ç; Balin M; Gul E; Kobat MA; Gumusay U; Sahan M; Bursal KB; Celiker I; Aydin S; Aydin S
J Investig Med; 2013 Jun; 61(5):852-5. PubMed ID: 23524986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
